comparemela.com
Latest Breaking News On - Prnewswire neuspera - Page 1 : comparemela.com
NEUSPERA MEDICAL® ANNOUNCES FIRST SUCCESSFUL IMPLANT OF THE NUVELLA™ SYSTEM IN THE SECOND PHASE OF ITS SANS-UUI IDE CLINICAL TRIAL
Study to support U.S. FDA approval of sacral neuromodulation device in patients with urinary urgency incontinence symptomsSAN JOSE, Calif., Oct. 1.
United-states
Minnesota
American
Melissa-farina
Prnewswire-neuspera
Jodi-michaels
Steffen-hovard
Society-of-urodynamics
Neuspera-medical-inc
American-urological-association
Minnesota-urology
Female-pelvic-medicine
Neuspera Medical Inc.: NEUSPERA MEDICAL ANNOUNCES SECOND PHASE OF SANS-UUI IDE CLINICAL TRIAL WITH THE NUVELLA SYSTEM
Pivotal trial to study the safety and efficacy of sacral nerve stimulation in patients with urinary urgency incontinence symptoms SAN JOSE, Calif., June 14, 2022 /PRNewswire/ Neuspera
United-states
American
Prnewswire-neuspera
Kostenloser-wertpapierhandel
Alexander-yeh
Steven-siegel
Neuspera-nuvella
Piper-sandler-investment-research
Society-of-urodynamics
Neuspera-medical-inc
American-urological-association
Chief-technology-officer
vimarsana © 2020. All Rights Reserved.